Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 238

1.

Association of E2F3 expression with clinicopathological features of Wilms' tumors.

An Q, Wang Y, An R, Li Y, Yao T, Zhai B, Sun X.

J Pediatr Surg. 2013 Nov;48(11):2187-93. doi: 10.1016/j.jpedsurg.2013.05.014.

PMID:
24210184
2.

Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.

Safford SD, Freemerman AJ, Langdon S, Bentley R, Goyeau D, Grundy PE, Skinner MA.

J Pediatr Surg. 2005 Feb;40(2):341-8.

PMID:
15750927
3.

Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome.

Lahoti C, Thorner P, Malkin D, Yeger H.

Am J Pathol. 1996 May;148(5):1577-89.

4.
5.

Expression of WT1 protein in fetal kidneys and Wilms tumors.

Grubb GR, Yun K, Williams BR, Eccles MR, Reeve AE.

Lab Invest. 1994 Oct;71(4):472-9.

PMID:
7967503
6.

RNA expression of the WT1 gene in Wilms' tumors in relation to histology.

Miwa H, Tomlinson GE, Timmons CF, Huff V, Cohn SL, Strong LC, Saunders GF.

J Natl Cancer Inst. 1992 Feb 5;84(3):181-7.

PMID:
1311774
7.

Blastemal expression of type I insulin-like growth factor receptor in Wilms' tumors is driven by increased copy number and correlates with relapse.

Natrajan R, Reis-Filho JS, Little SE, Messahel B, Brundler MA, Dome JS, Grundy PE, Vujanic GM, Pritchard-Jones K, Jones C.

Cancer Res. 2006 Dec 1;66(23):11148-55.

8.

Expression of apoptosis, cell proliferation, and drug resistance genes in pediatric Wilms' tumors.

Ramachandran C, Melnick SJ, Escalon E, Jhabvala P, Khatib Z, Alamo A, Smith S.

Anticancer Res. 2000 Sep-Oct;20(5C):3759-65.

PMID:
11268451
9.

[Expression of Stat3, HIF-1alpha and VEGF in Wilms' tumor].

Niu ZB, Wang CL, Hou Y, Yang Y, Gao H.

Zhongguo Dang Dai Er Ke Za Zhi. 2007 Oct;9(5):461-4. Chinese.

PMID:
17937859
10.

Distinctive properties of an anaplastic Wilms' tumor and its associated epithelial cell line.

Hazen-Martin DJ, Re GG, Garvin AJ, Sens DA.

Am J Pathol. 1994 May;144(5):1023-34.

11.
12.

The E2F3-Oncomir-1 axis is activated in Wilms' tumor.

Kort EJ, Farber L, Tretiakova M, Petillo D, Furge KA, Yang XJ, Cornelius A, Teh BT.

Cancer Res. 2008 Jun 1;68(11):4034-8. doi: 10.1158/0008-5472.CAN-08-0592.

13.

Topoisomerase IIalpha in Wilms' tumour: gene alterations and immunoexpression.

Tretiakova M, Turkyilmaz M, Grushko T, Kocherginsky M, Rubin C, Teh B, Yang XJ.

J Clin Pathol. 2006 Dec;59(12):1272-7. Epub 2006 Mar 23.

14.

Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma.

Ghanem MA, Van der Kwast TH, Den Hollander JC, Sudaryo MK, Oomen MH, Noordzij MA, Van den Heuvel MM, Nassef SM, Nijman RM, Van Steenbrugge GJ.

Clin Cancer Res. 2000 Nov;6(11):4265-71.

15.

SIX2 and CITED1, markers of nephronic progenitor self-renewal, remain active in primitive elements of Wilms' tumor.

Murphy AJ, Pierce J, de Caestecker C, Taylor C, Anderson JR, Perantoni AO, de Caestecker MP, Lovvorn HN 3rd.

J Pediatr Surg. 2012 Jun;47(6):1239-49. doi: 10.1016/j.jpedsurg.2012.03.034.

16.

Insulin-like growth factor II messenger ribonucleic acid expression in Wilms tumor, nephrogenic rest, and kidney.

Yun K, Molenaar AJ, Fiedler AM, Mark AJ, Eccles MR, Becroft DM, Reeve AE.

Lab Invest. 1993 Nov;69(5):603-15.

PMID:
7504120
17.

[Expression and promoter methylation of SIX2 gene in peripheral blood of pediatric patients with nephroblastoma].

Song DJ, Yue LF, Yang HY, Jia XY, Zhang JJ, Xu YL, Guo F, Wang JX.

Zhonghua Yi Xue Za Zhi. 2013 Jun 25;93(24):1876-80. Chinese.

PMID:
24124738
18.

Clinicopathological parameters and prognostic relevance of miR-21 and PTEN expression in Wilms' tumor.

Cui M, Liu W, Zhang L, Guo F, Liu Y, Chen F, Liu T, Ma R, Wu R.

J Pediatr Surg. 2017 Aug;52(8):1348-1354. doi: 10.1016/j.jpedsurg.2016.12.005. Epub 2016 Dec 20.

PMID:
28040201
19.

Expression and localization of HGF and met in Wilms' tumours.

Alami J, Williams BR, Yeger H.

J Pathol. 2002 Jan;196(1):76-84.

PMID:
11748645
20.

High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor.

Dome JS, Chung S, Bergemann T, Umbricht CB, Saji M, Carey LA, Grundy PE, Perlman EJ, Breslow NE, Sukumar S.

Cancer Res. 1999 Sep 1;59(17):4301-7.

Supplemental Content

Support Center